Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that a strategy using prophylactic oral Tranexamic Acid (TXA) with
therapeutic platelet transfusions is safe and effective compared to prophylactic platelet
transfusions in patients undergoing an autologous hematopoietic stem cell transplantation
(who are at risk for bleeding).